Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 3—March 2017

Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007–2012

Cara D. VarleyComments to Author , Jennifer H. Ku, Emily Henkle, Sean D. Schafer, and Kevin L. Winthrop
Author affiliations: Tulane University, New Orleans, Louisiana, USA (C.D. Varley); Oregon Health & Science University, Portland, Oregon, USA (C.D. Varley, J.H. Ku, E. Henkle, K.L. Winthrop); Oregon Department of Human Services, Portland (C.D. Varley, E. Henkle, S.D. Schafer)

Main Article

Table 1

Characteristics of 37 patients with HIV and disseminated NTM infection, Oregon, USA, 2007–2012*

  White 26 (70.3)
  Black 6 (16.2)
  Asian, Native American, Alaskan Native, Pacific Islander, >1 race 5 (13.5)
8 (21.6)
Female sex
9 (24.3)
Age at disseminated NTM diagnosis, y, median (range) 40 (22.7–59.4)
Deceased at time of data analysis
19 (52.8)
Time from HIV diagnosis to NTM diagnosis, y, median (range)
2.1 (0–20.7)
NTM species
  M. aubagnense 1 (2.7)
  M. avium 35 (94.6)
  M. chelonae
1 (2.7)
CD4 count, cells/mm3)† 10 (1–414)
  <50 23 (74.2)
  50–100 5 (16.1)
  101–200 1 (3.2)
2 (6.5)
Viral load, copies/mL, median (range) 131,446 (0–4,570,000)

*Values are no. (%) except as indicated. NTM, nontuberculous mycobacteria.
†CD4 count missing for 6 patients.

Main Article

Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.